发明名称 Nitrogen-containing bicyclic aromatic heterocyclic compound
摘要 On the basis of a cathepsin S inhibitory effect, an excellent agent for treating or preventing autoimmune disease, allergic disease, graft rejection of an organ, bone marrow or tissue, systemic lupus erythematosus, or the like is provided. It was found that a nitrogen-containing bicyclic heterocyclic compound has an excellent cathepsin S inhibitory effect, thereby completing the invention. The compound of the present invention has an cathepsin S inhibitory effect, and can be used as an agent for preventing and/or treating autoimmune disease, allergic disease, graft rejection of an organ, bone marrow or tissue, systemic lupus erythematosus, or the like.
申请公布号 US9585889(B2) 申请公布日期 2017.03.07
申请号 US201615017914 申请日期 2016.02.08
申请人 Astellas Pharma Inc. 发明人 Nakajima Yutaka;Imada Sunao;Takasuna Yuji;Aoyama Naohiro;Nigawara Takahiro;Shirakami Shohei;Shirai Fumiyuki;Sato Junji;Nakanishi Keita;Kubo Kaori
分类号 A61K31/519;A61K31/52;C07D473/00;C07D487/04;A61K31/5377 主分类号 A61K31/519
代理机构 Oblon, McClelland, Maier & Neustadt, L.L.P. 代理人 Oblon, McClelland, Maier & Neustadt, L.L.P.
主权项 1. A method for treating systemic lupus erythematosus or lupus nephritis, comprising administering to a patient in need thereof an effective amount of a compound or a salt thereof, which is selected from the group consisting of: 6-{6-[2-(1-ethylpiperidin-4-yl}ethoxy]-5-(trifluoromethyl)pyridin-3-yl}-9-methyl-9H-purine-2-carbonitrile or a salt thereof; and 4-{6-[2-(1-ethylpiperidin-4-yl)ethoxy]-5-(trifluoromethyl)pyridin-3-yl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile or a salt thereof.
地址 Chuo-ku JP